Presentation is loading. Please wait.

Presentation is loading. Please wait.

Proposed Revision Of The Staging Classification For Esophageal Cancer

Published byΣιμωνίδης Κουβέλης Modified over 5 years ago

Similar presentations

Presentation on theme: "Proposed Revision Of The Staging Classification For Esophageal Cancer"— Presentation transcript:

1 Proposed Revision Of The Staging Classification For Esophageal Cancer
Robert J. Korst, MDa, Valerie W. Rusch, MDa, Ennapadam Venkatraman, PhDb, Manjit S. Bains, MDa, Michael E. Burt, MD, PhDa, Robert J. Downey, MDa, Robert J. Ginsberg, MDa  The Journal of Thoracic and Cardiovascular Surgery  Volume 115, Issue 3, Pages (March 1998) DOI: /S (98) Copyright © 1998 Mosby, Inc. Terms and Conditions

2 Fig. 1 Lymph node mapping system for esophageal cancer. RUL, Right upper lobe; LUL, left upper lobe. Stations 11 (interlobar), 12 (lobar), 13 (segmental), and 14 (subsegmental) are intrapulmonary nodes and have been excluded. (From Casson AG, Rusch VW, Inculet RI, Ginsberg RJ, Zankowicz N, Rosenberg JC, et al. Lymph node mapping for resectable carcinoma of the esophagus: a guide for thoracic surgeons. Princeton (NJ): Bristol-Myers Oncology Division; Reproduced with permission.) The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

3 Fig. 2 A, Overall survival according to TNM stage. The revised staging system is noted in parentheses. B,Overall survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

4 Fig. 2 A, Overall survival according to TNM stage. The revised staging system is noted in parentheses. B,Overall survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

5 Fig. 3 A, Disease-free survival according to TNM stage. The revised staging system is noted in parentheses. B,Disease-free survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

6 Fig. 3 A, Disease-free survival according to TNM stage. The revised staging system is noted in parentheses. B,Disease-free survival according to the newly proposed stage groupings with the revised TNM system. Table V describes stage groupings. Stage IV (T4, any N, M0 and any T, any N, M1) is not depicted. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

7 Fig. 4 A, Overall survival according to number of positive lymph nodes. B,Overall survival curves of patients with significantly different prognoses according to the number of positive lymph nodes. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

8 Fig. 4 A, Overall survival according to number of positive lymph nodes. B,Overall survival curves of patients with significantly different prognoses according to the number of positive lymph nodes. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions

Download ppt "Proposed Revision Of The Staging Classification For Esophageal Cancer"

Similar presentations

Esophageal Cancer CHEST

Esophageal Cancer CHEST
The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.

The prognostic importance of the number of involved lymph nodes in esophageal cancer: Implications for revisions of the American Joint Committee on Cancer.
Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.

Assessment of Lymph Node Ratio to Replace the pN Categories System of Classification of the TNM System in Esophageal Squamous Cell Carcinoma  Yingjie.
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography  Walter.

Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomography  Walter.
Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,

Ratio of Metastatic Lymph Nodes to Total Number of Nodes Resected is Prognostic for Survival in Esophageal Carcinoma  Clive J. Kelty, MB, ChB, PhD, FRCSEd,
Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than.

Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than.
Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.

Validation of the Stage Groupings in the Eighth Edition of the TNM Classification for Lung Cancer  Xizhao Sui, MD, Wei Jiang, MD, Haiqing Chen, MD, Fan.
Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.

Prognostic evaluation based on a new TNM staging system proposed by the International Association for the Study of Lung Cancer for resected non–small.
Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: Implications for therapy  John J. Nigro, MD, Jeffrey.

Prevalence and location of nodal metastases in distal esophageal adenocarcinoma confined to the wall: Implications for therapy  John J. Nigro, MD, Jeffrey.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Tumors of the esophagogastric junction

Tumors of the esophagogastric junction
Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer  Robert E. Merritt, MD, Chuong D. Hoang, MD,
Appraisal of a Revised Lymph Node Classification System for Esophageal Squamous Cell Cancer  Dipok Kumar Dhar, PhD, Shinji Hattori, MD, Yasuhito Tonomoto,

Appraisal of a Revised Lymph Node Classification System for Esophageal Squamous Cell Cancer  Dipok Kumar Dhar, PhD, Shinji Hattori, MD, Yasuhito Tonomoto,
Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.

Which is the Better Prognostic Factor for Resected Non-small Cell Lung Cancer: The Number of Metastatic Lymph Nodes or the Currently Used Nodal Stage.
Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy  Morihito Okada, MD, Hiroyuki Yamagishi,

Similar presentations

Ads by Google